Insider Stock Trading History of Heyrman Reinilde


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Heyrman Reinilde since year 2005. The trader's CIK number is 1630929. At the time of this reporting, Heyrman Reinilde is the Chief Clinical Dev. Officer of Bellerophon Therapeutics, Inc. . (stock ticker symbol BLPH). See this page for all insider trading activities at Bellerophon Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Heyrman Reinilde since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-02-19 BLPH Bellerophon Therapeutics, Inc. Buy 1,500 12.00 18,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Heyrman Reinilde (Chief Clinical Dev. Officer of Bellerophon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.